Eiger BioPharmaceuticals

-$0.58 (-6.28%) Today
+$0.10 (+1.16%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell EIGR and other stocks, options, and ETFs commission-free!

About EIGR

Eiger BioPharmaceuticals, Inc. engages in the development and commercialization of foundational therapies for Hepatitis Delta Virus. It is also developing avexitide as a treatment for Post-Bariatric Hypoglycemia.

CEO
David A. Cory
Employees
28
Headquarters
Palo Alto, California
Founded
2008

EIGR Key Statistics

Market Cap
277.04M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
234.72K
High Today
$9.18
Low Today
$8.12
Open Price
$9.18
Volume
377.32K
52 Week High
$13.99
52 Week Low
$7.57

EIGR Earnings

-$0.76
-$0.22
$0.31
$0.85
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
$0.85 per share
Replay Earnings Call

You May Also Like

IIPR
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure